Mutation of c-Met RTK: A novel molecular therapeutic target for the treatment of mesothelioma

被引：0
|
作者：
Jagadeeswaran, Ramasamy
Ma, Patrick C.
Seiwert, Tanguy Y.
Jagadeeswaran, Sujatha
Zumba, Osvaldo
Nallasura, Vidya
Ahmed, Salman
Kratzke, Robert A.
Gordon, Gavin J.
Sugarbaker, David J.
Bueno, Raphael
Janamanchi, Varalakshmi
Bindokas, Vytas P.
Kindler, Hedy L.
Salgia, Ravi
机构：
[1] Univ Chicago, Sect Hematol Oncol, Canc Res Ctr, Dept Med,Med Ctr,Pritzker Sch Med, Chicago, IL 60637 USA
[2] Univ Minnesota, Sch Med, Dept Surg, Div Cardiovasc & Thorac Surg, Minneapolis, MN 55455 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Surg,Div Thorac Surg, Boston, MA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3028
引用
收藏
页数：2
相关论文
共 50 条
  • [41] c-Met: A new target for nanoparticle therapeutics
    Harris, Alesha
    Phelps, Amanda
    Petros, Robby A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [42] c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
    Granito, Alessandro
    Guidetti, Elena
    Gramantieri, Laura
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2015, 2 : 29 - 38
  • [43] Novel germline c-MET mutation in a family with hereditary papillary renal carcinoma
    Karin A. W. Wadt
    Anne-Marie Gerdes
    Thomas V. O. Hansen
    Birgitte G. Toft
    Lennart Friis-Hansen
    Mette K. Andersen
    Familial Cancer, 2012, 11 : 535 - 537
  • [44] Expression of c-Met in malignant pleural mesothelioma: an immunohistochemical study
    Wagih, H.
    Gamal, A.
    Abdelaty, N.
    Ekram, A.
    ALLERGY, 2007, 62 : 561 - 561
  • [45] C-Met is a potential therapeutic target for antibody-drug conjugates in breast cancer
    Fu, Yanwen
    Gros, Edwige
    Lee, Alice
    Johnson, Kimberly
    Zhang, Hong
    Yalamanchili, Silpa
    Motamed, Kouros
    Chen, Gary
    Jones, Bryan
    Miao, David
    Kaufmann, Gunnar F.
    CANCER RESEARCH, 2015, 75
  • [46] c-Met: a New Cancer Stem Cell Marker and Therapeutic Target for Pancreatic Cancer
    Wu, J-J.
    Li, C.
    Hynes, M.
    Dosch, J.
    Sarkar, B.
    Magliano, M. P.
    Simeone, D. M.
    PANCREAS, 2011, 40 (08) : 1363 - 1363
  • [47] The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis
    You, Weon-Kyoo
    McDonald, Donald M.
    BMB REPORTS, 2008, 41 (12) : 833 - 839
  • [48] Target proteins involved in resistance to c-Met inhibitors and their therapeutic role in human melanoma
    Fong, Jason T.
    Puri, Neelu
    CANCER RESEARCH, 2011, 71
  • [49] Isothiocyanatostilbenes as novel c-Met inhibitors
    Gray, Alana L.
    Coleman, David T.
    Castore, Reneau F.
    Mohyeldin, Mohamed M.
    El Sayed, Khalid A.
    Cardelli, James A.
    ONCOTARGET, 2015, 6 (38) : 41180 - 41193
  • [50] Isothiocyanatostilbenes as novel c-Met inhibitors
    Gray, A. L.
    Coleman, D. T.
    Castore, R. F.
    Mohyeldin, M. M.
    El Sayed, K. A.
    Cardelli, J. A.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
12345